Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Cubist enters agreement with Novartis for antiinfective drug discovery

Feb. 12, 1999

In vitro and in vivo profile of antifungal activity reported for FK-463

Feb. 11, 1999

Renal toxicity of NS-718 and amphotericin B compared in laboratory and animal studies

Feb. 11, 1999

Zeneca patents new class of DNA gyrase-inhibiting antibiotics

Feb. 11, 1999

Biota's inhaled influenza drug recommended for approval in Australia

Feb. 10, 1999

Trovan I.V. potentially incompatible with normal saline and lactated Ringer's solutions

Feb. 10, 1999

New antibacterial series produced by Streptomyces discovered by Kyowa Hakko

Feb. 10, 1999

Status update for OPB-2045

Feb. 9, 1999

Oxazolidinones from P&U with broad-spectrum antibacterial activity

Feb. 9, 1999

New antiviral agents from SB for herpesvirus infections

Feb. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...